<a href="https://laohu8.com/S/SOPH">SOPHiA GENETICS SA</a> Reports 15.9% Increase in Six-Month Revenue, Net Loss Widens by 35.5%
SOPHiA GENETICS SA has released its unaudited interim financial results for the first half of 2025. The company reported a revenue increase to $36.1 million for the six months ended June 30, 2025, compared to $31.6 million in the same period in 2024, marking a significant rise. However, the company recorded a loss before tax of $38.5 million for the first half of 2025, compared to a loss of $28.4 million in the corresponding period of the previous year. A notable increase in share-based compensation, which rose to $8.2 million from $7.8 million in 2024, contributed to the overall financial results. The company has not provided any specific outlook or guidance for future periods in the released interim statements. SOPHiA GENETICS continues to operate in a single segment, with its revenues being assessed across Europe, the Middle East, and Africa (EMEA); North America (NORAM); Latin America (LATAM); and Asia-Pacific (APAC).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001840706-25-000026), on August 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.